Mammalian Cell Fermentation Technology Market, By Type (Baby Hamster Kidney (BHK) Cell Fermentation, Chinese Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Murine Myeloma Cell Fermentation, and Others), By Application, By End-use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Mammalian cell fermentation technology Market size was valued at US$ 50,789.43 Million in 2024, expanding at a CAGR of 8.99% from 2025 to 2032.
Mammalian cells play a crucial role in producing therapeutic proteins, including vaccines, monoclonal antibodies, and other biologics. Commonly used cell lines such as Human Embryonic Kidney (HEK) cells and Chinese Hamster Ovary (CHO) cells serve as key sources for biopharmaceutical manufacturing. The mammalian cell fermentation technology sector is poised for significant growth in the coming years, driven by increasing demand for biosimilars and biologics, a rising prevalence of chronic diseases, and continuous advancements in cell culture techniques. As biopharmaceutical companies focus on improving efficiency and scalability, innovations in mammalian cell-based production methods are expected to enhance the development of high-quality, cost-effective therapeutics, further fueling market expansion.
Mammalian Cell Fermentation Technology Market- Market Dynamics
Ø Increasing demand for biologics and biosimilars to propel market growth
The mammalian cell fermentation technology sector is experiencing notable growth due to the increasing demand for biosimilars and biologics. These therapies play a crucial role in treating various conditions, including infectious diseases, cancer, and autoimmune disorders. Moreover, the expansion of mammalian cell fermentation technology continues as pharmaceutical companies invest more in developing new biologics. However, a key challenge limiting the widespread adoption of this technology is the high cost of its manufacturing process. Additionally, the growing prevalence of chronic diseases such as cancer, diabetes, and heart disease has fueled the expansion of the mammalian cell fermentation technology market. With many conditions requiring long-term treatment, often involving biologics, the demand for mammalian cell fermentation technologies remains strong. Consequently, the market is expected to grow in the coming years due to the persistent need for biosimilars, biologics, and treatments for chronic illnesses.
Mammalian Cell Fermentation Technology Market- Segmentation Analysis:
The global mammalian cell fermentation technology market is segmented on the basis of type, application, end-use, and region.
The market is divided into five categories based on type: baby hamster kidney (BHK) cell fermentation, chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) Cell fermentation, murine myeloma cell fermentation, and others. The Chinese Hamster Ovary (CHO) cell fermentation sector is anticipated to lead the market. CHO cells have gained significant attention due to their efficiency in producing complex therapeutic proteins. Furthermore, the increasing demand is driven by multiple factors, including the optimization of culture media and conditions, advancements in genetic engineering techniques for improving cell line development, and a strong regulatory framework.
The market is divided into six categories based on application: enzymes, hormones, monoclonal antibodies, recombinant proteins, vaccines, others. The monoclonal antibodies segment is expected to capture the largest market share, driven by the essential role antibodies play in diagnostic and therapeutic applications, resulting in increased demand for efficient production methods. Additionally, innovations in cell line development, bioreactor technologies, and bioprocessing techniques have enhanced product quality, boosted yields, and optimized production efficiency, accelerating the segment’s rapid growth. Similarly, the rising demand for highly targeted therapies and the growing incidence of chronic diseases have further contributed to the increasing need for mammalian antibodies.
The market is divided into three categories based on end-use: academic & research institutes, biopharmaceutical companies, and CMOs & CDMOs. The CMOs & CDMOs sector is expected to sustain its dominance throughout the forecast period, driven by the specialized expertise these organizations offer in complex manufacturing techniques. They provide cost-effective and streamlined solutions for companies looking to outsource production, enabling a stronger focus on research and development. Additionally, stricter quality standards and regulatory requirements have led pharmaceutical firms to partner with trusted CMOs and CDMOs that possess the necessary expertise to meet these compliance demands.
Mammalian Cell Fermentation Technology Market- Geographical Insights
North America dominates the mammalian cell fermentation technology market, supported by its advanced healthcare infrastructure, favorable government regulations, and the strong presence of leading biopharmaceutical companies. The region\'s growing demand for biologics and biosimilars, coupled with the rising prevalence of chronic diseases, continues to drive market expansion. Additionally, ongoing research and development efforts, along with substantial investments in biopharmaceutical manufacturing, further strengthen North America’s market position. Meanwhile, the Asia Pacific region is poised for rapid growth, driven by an expanding pool of skilled professionals at lower costs, a favorable regulatory environment, and increasing investments from multinational corporations. The region\'s growing biotechnology sector and advancements in cell culture technologies further contribute to market expansion. As both regions focus on innovation and scalability, the global mammalian cell fermentation technology market is expected to witness sustained growth, shaping the future of biopharmaceutical production.
Mammalian Cell Fermentation Technology Market- Competitive Landscape:
The mammalian cell fermentation market is driven by technological advancements in cell culture. The increasing demand for this technology across various applications has created multiple opportunities for key industry players to leverage. Leading companies primarily implement strategies such as acquisitions, collaborations, partnerships, and mergers to expand their global presence and stay competitive. Additionally, market growth is fueled by continuous research and development efforts to improve bioprocessing techniques, along with rising investments in biomanufacturing infrastructure. For example, in January 2023, Fosun Pharma entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc. in the United States (US) for the commercialization of Henlius\' independently developed anti-PD-1 monoclonal antibody (mAb) serplulimab, marking a pivotal milestone in Fosun Pharma’s expansion in the US.
Recent Developments:
v In July 2023, Lonza introduced the TheraPRO® CHO Media System, an advanced cell culture platform designed to enhance efficiency and improve protein quality when used with GS-CHO cell lines. This innovation aids biotechnology and pharmaceutical companies in therapeutic protein production by optimizing product quality and accelerating time-to-market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø AstraZeneca
Ø Danaher
Ø Thermo Fisher Scientific, Inc.
Ø Regeneron Pharmaceuticals
Ø Merck KGaA
Ø Lonza
Ø Gilead Sciences
Ø F. Hoffmann-La Roche Ltd
Ø Moderna, Inc
Ø Bristol-Myers Squibb
Ø Amgen
Ø Sartorius AG
Ø Others
GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Baby Hamster Kidney (BHK) Cell Fermentation
Ø Chinese Hamster Ovary (CHO) Cell Fermentation
Ø Human Embryonic Kidney (HEK) Cell Fermentation
Ø Murine Myeloma Cell Fermentation
Ø Others
GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Enzymes
Ø Hormones
Ø Monoclonal Antibodies
Ø Recombinant Proteins
Ø Vaccines
Ø Others
GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
Ø Academic & Research Institutes
Ø Biopharmaceutical Companies
Ø CMOs & CDMOs
GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o U.S.
o Canada
Ø Europe
o Germany
o UK
o France
o Italy
o Spain
o The Netherlands
o Sweden
o Russia
o Poland
o Rest of Europe
Ø Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Thailand
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Mammalian Cell Fermentation Technology Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Mammalian Cell Fermentation Technology Market Snippet by Type
2.1.2. Mammalian Cell Fermentation Technology Market Snippet by Application
2.1.3. Mammalian Cell Fermentation Technology Market Snippet by End-use
2.1.4. Mammalian Cell Fermentation Technology Market Snippet by Country
2.1.5. Mammalian Cell Fermentation Technology Market Snippet by Region
2.2. Competitive Insights
3. Mammalian Cell Fermentation Technology Key Market Trends
3.1. Mammalian Cell Fermentation Technology Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Mammalian Cell Fermentation Technology Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Mammalian Cell Fermentation Technology Market Opportunities
3.4. Mammalian Cell Fermentation Technology Market Future Trends
4. Mammalian Cell Fermentation Technology Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Mammalian Cell Fermentation Technology Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Mammalian Cell Fermentation Technology Market Landscape
6.1. Mammalian Cell Fermentation Technology Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Mammalian Cell Fermentation Technology Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
7.1.2. Baby Hamster Kidney (BHK) Cell Fermentation
7.1.3. Chinese Hamster Ovary (CHO) Cell Fermentation
7.1.4. Human Embryonic Kidney (HEK) Cell Fermentation
7.1.5. Murine Myeloma Cell Fermentation
7.1.6. Others
8. Mammalian Cell Fermentation Technology Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
8.1.2. Enzymes
8.1.3. Hormones
8.1.4. Monoclonal Antibodies
8.1.5. Recombinant Proteins
8.1.6. Vaccines
8.1.7. Others
9. Mammalian Cell Fermentation Technology Market – By End-use
9.1. Overview
9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
9.1.2. Academic & Research Institutes
9.1.3. Biopharmaceutical Companies
9.1.4. CMOs & CDMOs
10. Mammalian Cell Fermentation Technology Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Mammalian Cell Fermentation Technology Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Mammalian Cell Fermentation Technology Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Mammalian Cell Fermentation Technology Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Mammalian Cell Fermentation Technology Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Mammalian Cell Fermentation Technology Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Mammalian Cell Fermentation Technology Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. AstraZeneca
11.2.2. Danaher
11.2.3. Thermo Fisher Scientific, Inc.
11.2.4. Regeneron Pharmaceuticals
11.2.5. Merck KGaA
11.2.6. Lonza
11.2.7. Gilead Sciences
11.2.8. F. Hoffmann-La Roche Ltd
11.2.9. Moderna, Inc
11.2.10. Bristol-Myers Squibb
11.2.11. Amgen
11.2.12. Sartorius AG
11.2.13. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
